Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birkmayer

Showing results (91-100 of 134) with videos related to

Pageof 14
Sort By:
Wiener Medizinische Wochenschrift (1946)|October 19, 2002
[Stabilized NADH (ENADA) improves jet lag-induced cognitive performance deficit]G D Birkmayer, G G Kay, E Vürre
Journal of Neural Transmission|January 1, 1984
L-deprenyl plus L-phenylalanine in the treatment of depressionW Birkmayer, P Riederer, W Linauer, et al.
Hoppe-Seyler'S Zeitschrift Fur Physiologische Chemie|November 1, 1972
Inhibition of high molecular weight RNA synthesis in a hamster melanoma by ethidium bromide in vivoG D Birkmayer, F Miller, B R Balda
Deutsche Medizinische Wochenschrift (1946)|May 17, 1974
[Statistical aspects of the tyrosine-tryptophan diagram in depression (author's transl)]L Ambrozi, P Riederer, W Birkmayer, et al.
European Journal of Cancer|November 1, 1973
The inhibitory effect of proflavine and ethidiumbromide on the cell-free transmission and the growth of the hamster melanoma A Mel 3G D Birkmayer, B R Balda, F Miller
Advances in Biochemical Psychopharmacology|January 1, 1978
Monoamine oxidase activity during (--)-deprenil therapy: human brain post-mortem studiesP Riederer, M B Youdim, W Birkmayer, et al.
British Journal of Pharmacology|November 1, 1976
L-dopa and (-)-deprenil in the treatment of Parkinson's disease: a long-term study [proceedings]L Ambrozi, W Birkmayer, P Riederer, et al.
Modern Problems of Pharmacopsychiatry|January 1, 1983
(-)-Deprenyl leads to prolongation of L-dopa efficacy in Parkinson's diseaseW Birkmayer, J Knoll, P Riederer, et al.
Lancet (London, England)|February 26, 1977
Implications of combined treatment with 'Madopar' and L-deprenil in Parkinson's disease. A long-term studyW Birkmayer, P Riederer, L Ambrozi, et al.
Archiv Fur Klinische Und Experimentelle Dermatologie|January 1, 1970
Differences in cytochrome oxidase and mitochondrial ATPase in melanotic and amelanotic melanomaG D Birkmayer, B R Balda, O Braun-Falco
Pageof 14

Showing results (91-100 of 134) with videos related to

Sort By:
Pageof 14
Wiener Medizinische Wochenschrift (1946)|October 19, 2002
[Stabilized NADH (ENADA) improves jet lag-induced cognitive performance deficit]G D Birkmayer, G G Kay, E Vürre
Journal of Neural Transmission|January 1, 1984
L-deprenyl plus L-phenylalanine in the treatment of depressionW Birkmayer, P Riederer, W Linauer, et al.
Hoppe-Seyler'S Zeitschrift Fur Physiologische Chemie|November 1, 1972
Inhibition of high molecular weight RNA synthesis in a hamster melanoma by ethidium bromide in vivoG D Birkmayer, F Miller, B R Balda
Deutsche Medizinische Wochenschrift (1946)|May 17, 1974
[Statistical aspects of the tyrosine-tryptophan diagram in depression (author's transl)]L Ambrozi, P Riederer, W Birkmayer, et al.
European Journal of Cancer|November 1, 1973
The inhibitory effect of proflavine and ethidiumbromide on the cell-free transmission and the growth of the hamster melanoma A Mel 3G D Birkmayer, B R Balda, F Miller
Advances in Biochemical Psychopharmacology|January 1, 1978
Monoamine oxidase activity during (--)-deprenil therapy: human brain post-mortem studiesP Riederer, M B Youdim, W Birkmayer, et al.
British Journal of Pharmacology|November 1, 1976
L-dopa and (-)-deprenil in the treatment of Parkinson's disease: a long-term study [proceedings]L Ambrozi, W Birkmayer, P Riederer, et al.
Modern Problems of Pharmacopsychiatry|January 1, 1983
(-)-Deprenyl leads to prolongation of L-dopa efficacy in Parkinson's diseaseW Birkmayer, J Knoll, P Riederer, et al.
Lancet (London, England)|February 26, 1977
Implications of combined treatment with 'Madopar' and L-deprenil in Parkinson's disease. A long-term studyW Birkmayer, P Riederer, L Ambrozi, et al.
Archiv Fur Klinische Und Experimentelle Dermatologie|January 1, 1970
Differences in cytochrome oxidase and mitochondrial ATPase in melanotic and amelanotic melanomaG D Birkmayer, B R Balda, O Braun-Falco
Pageof 14